ToxStrategies is at World Orphan Drug Congress in Boston!
ToxStrategies is excited to be attending, exhibiting, and hosting a round table at the World Orphan Drug Congress (WODC), April 23–25, 2024. This… read more
Latest News
ToxStrategies Identified as a Preferred Vendor for a Multinational Retailer to Support Safety Substantiation under MoCRA
A multinational retailer has identified ToxStrategies as one of its preferred vendors for safety substantiation of cosmetic products manufactured by its private label… read more
Food and Supplements Industries Eye New NDIN Guidance from FDA
The Food and Drug Administration has released a Final Guidance for Industry to address some ongoing issues with procedures and timing for submitting… read more
ToxStrategies is Presenting and Exhibiting at SOT 2024!
ToxStrategies is excited to be attending, presenting, and exhibiting at the Society of Toxicology’s 63rd Annual Meeting and ToxExpo, March 9th 2024, to… read more
Healthcare resource use by PSVT patients undergoing cardiac ablation
HEORStrategies’ Dr. Naomi Sacks is a co-author on a study of healthcare resource use and costs in cardiac arrhythmia patients with paroxysmal supraventricular… read more
EPA issues a framework for identifying eye irritation or corrosion hazards for new chemicals reviewed under TSCA, prioritizing non-animal methods
On January 8, 2024, EPA issued a new framework for identifying eye irritation or corrosion hazards for new chemicals reviewed under the Toxic… read more
ToxStrategies has exciting news from the FDA Center for Veterinary Medicine!
The Center for Veterinary Medicine (CVM) is paving the way for innovation in the animal feed industry! In a recent Letter to Industry,… read more
Final Rule on reporting and recordkeeping requirements for PFAS
The US Environmental Protection Agency (EPA) has issued a final rule on reporting and recordkeeping requirements for per- and polyfluoroalkyl substances (PFAS) through… read more